Pyridoxine 5'-phosphate oxidase is correlated with human breast invasive ductal carcinoma development.

作者: Weimin Ren , Wencai Guan , Jinguo Zhang , Fanchen Wang , Guoxiong Xu

DOI: 10.18632/AGING.101908

关键词: Cancer researchGene knockdownPNPOmicroRNAApoptosisMALAT1Pyridoxine 5'-phosphate oxidaseMetastasisCell cycleBiology

摘要: Pyridoxine 5'-phosphate oxidase (PNPO) is a converting enzyme for an active form of vitamin B6. This study aims to evaluate the biological function and regulatory mechanism PNPO in human breast invasive ductal carcinoma (IDC). We unveiled first time that was upregulated patients with IDC correlated overall survival metastasis at later stages. Suppression inhibited cancer cell proliferation, migration, invasion colony formation, arrested cycle G2/M phase induced apoptosis. positively lncRNA MALAT1 which negatively miR-216b-5p. down-regulated up-regulated by miR-216b-5p mimics inhibitors, respectively, cells. A microRNA response element found both transcripts dual-luciferase reporter assay confirmed binding these transcripts. Knockdown resulted increase decrease mRNA, indicating competing endogenous RNAs. Taken together, results reveal PNPO, MALAT1/miR-216b-5p/PNPO axis may be important development. Targeting this have therapeutic potential cancer.

参考文章(45)
D Chalbos, F Galtier, Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription. Journal of Biological Chemistry. ,vol. 269, pp. 23007- 23012 ,(1994) , 10.1016/S0021-9258(17)31611-3
Annika Vienonen, Heimo Syvälä, Susanna Miettinen, Pentti Tuohimaa, Timo Ylikomi, Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 80, pp. 307- 313 ,(2002) , 10.1016/S0960-0760(02)00027-4
Jennifer K. Richer, Britta M. Jacobsen, Nicole G. Manning, M. Greg Abel, Douglas M. Wolf, Kathryn B. Horwitz, Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. Journal of Biological Chemistry. ,vol. 277, pp. 5209- 5218 ,(2002) , 10.1074/JBC.M110090200
Mariam H. Al-Dhaheri, Yatrik M. Shah, Venkatesha Basrur, Steven Pind, Brian G. Rowan, Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells Steroids. ,vol. 71, pp. 966- 978 ,(2006) , 10.1016/J.STEROIDS.2006.07.006
Martino Luigi di Salvo, Roberto Contestabile, Martin K. Safo, Vitamin B6 salvage enzymes: Mechanism, structure and regulation Biochimica et Biophysica Acta. ,vol. 1814, pp. 1597- 1608 ,(2011) , 10.1016/J.BBAPAP.2010.12.006
Lisa Braun, Friederike Mietzsch, Petra Seibold, Andreas Schneeweiss, Peter Schirmacher, Jenny Chang-Claude, Hans Peter Sinn, Sebastian Aulmann, Intrinsic breast cancer subtypes defined by estrogen receptor signalling—prognostic relevance of progesterone receptor loss Modern Pathology. ,vol. 26, pp. 1161- 1171 ,(2013) , 10.1038/MODPATHOL.2013.60
Patricia A. Mote, Anne Gompel, Chris Howe, Heidi N. Hilton, Ivana Sestak, Jack Cuzick, Mitch Dowsett, Danielle Hugol, Patricia Forgez, Karen Byth, J. Dinny Graham, Christine L. Clarke, Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial. Breast Cancer Research and Treatment. ,vol. 151, pp. 309- 318 ,(2015) , 10.1007/S10549-015-3397-0
Perry A. Frey, George H. Reed, Pyridoxal-5′-phosphate as the catalyst for radical isomerization in reactions of PLP-dependent aminomutases Biochimica et Biophysica Acta. ,vol. 1814, pp. 1548- 1557 ,(2011) , 10.1016/J.BBAPAP.2011.03.005
Charles M. Perou, Therese Sørlie, Michael B. Eisen, Matt van de Rijn, Stefanie S. Jeffrey, Christian A. Rees, Jonathan R. Pollack, Douglas T. Ross, Hilde Johnsen, Lars A. Akslen, Øystein Fluge, Alexander Pergamenschikov, Cheryl Williams, Shirley X. Zhu, Per E. Lønning, Anne-Lise Børresen-Dale, Patrick O. Brown, David Botstein, Molecular portraits of human breast tumours Nature. ,vol. 406, pp. 747- 752 ,(2000) , 10.1038/35021093